Cargando…
IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung Adenocarcinoma
SIMPLE SUMMARY: Lung cancer is the leading cause of cancer mortality worldwide. The most frequent group of lung cancer is the nonsmall cell lung carcinoma. The immune system of cancer patients participates in the crosstalk between inflammatory immune and nonimmune cells and cancer cells. This event...
Autores principales: | Islas-Vazquez, Lorenzo, Aguilar-Cazares, Dolores, Galicia-Velasco, Miriam, Rumbo-Nava, Uriel, Meneses-Flores, Manuel, Luna-Rivero, Cesar, Lopez-Gonzalez, Jose Sullivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694324/ https://www.ncbi.nlm.nih.gov/pubmed/33167343 http://dx.doi.org/10.3390/biology9110376 |
Ejemplares similares
-
LAP TGF-Beta Subset of CD4(+)CD25(+)CD127(−) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients
por: Islas-Vazquez, Lorenzo, et al.
Publicado: (2015) -
Old and New Players of Inflammation and Their Relationship With Cancer Development
por: Chavez-Dominguez, Rodolfo, et al.
Publicado: (2021) -
Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) to predict postoperative pneumonia in elderly hip fracture patients
por: Yao, Wei, et al.
Publicado: (2023) -
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
por: Chavez-Dominguez, Rodolfo L., et al.
Publicado: (2021) -
Chronic Urticaria Treatment with Omalizumab—Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy
por: Tarkowski, Bartłomiej, et al.
Publicado: (2023)